Joseph Matthew Rogers

Joseph Matthew Rogers is an Associate Professor in the Department of Drug Design and Pharmacology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on innovative approaches to drug discovery and protein engineering with particular emphasis on peptide-based therapeutics.

His research interests include:

• De novo protein and peptide design
• mRNA display technology for drug discovery
• GPCR-targeted therapeutics
• Computational approaches to protein engineering
• Development of peptide-based inhibitors
• Structural biology of protein-peptide interactions

Dr. Rogers' recent publications demonstrate a strong focus on applying advanced biotechnological approaches to address challenging problems in pharmacology. His work spans from designing miniprotein modulators for stroke treatment to engineering novel protein binders and cyclic peptide inhibitors. He has published in high-impact journals including Nature, Journal of the American Chemical Society, and Angewandte Chemie.

His research has received significant attention with publications being picked up by 18 news outlets, blogged about by multiple sources, and referenced by numerous social media users. His work has also been incorporated into clinical guideline sources, demonstrating its translational impact and relevance to medical practice.

Dr. Rogers maintains an active research program with 29 total research outputs including journal articles, conference abstracts, reviews, and book chapters. His work bridges the gap between basic science and therapeutic applications, with particular focus on neurological conditions and innovative drug modalities.